Viewing Study NCT01199757


Ignite Creation Date: 2025-12-24 @ 6:52 PM
Ignite Modification Date: 2026-01-13 @ 7:49 AM
Study NCT ID: NCT01199757
Status: COMPLETED
Last Update Posted: 2017-08-14
First Post: 2010-09-09
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Comparison of Patients on AVAMYS ® Versus NASONEX (A Trade Mark of Schering Corporation) and FLIXONASE ® on Key Health Outcome Measures
Sponsor: GlaxoSmithKline
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: 114812
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None INDUSTRY View